作者：
Matteo,Bellone [1]
;
Arianna,Brevi [1]
;
Stefania,Bruzzì [2]
;
Michela,Consonni [3]
;
Francesca,De Santis [4]
;
Giulia,Di Lullo [5]
;
Maria Teresa,Majorini [6]
;
Anna,Pastò [7]
;
Alberto,Amadori [8]
;
Marco,Bregni [9]
;
Massimo,Di Nicola [4]
;
Luana,Calabrò [10]
;
Pier Francesco,Ferrucci [11]
;
Enrico,Proietti [12]
;
Mario Paolo,Colombo [6]
;
Vincenzo,Russo [13]
作者单位：
Unit of Cellular Immunology, IRCCS Ospedale San Raffaele, Milan, Italy.
[1]
Unit of Immuno-Biotherapy of Melanoma and Solid Tumors, IRCCS Ospedale San Raffaele, Milan, Italy.
[2]
Unit of Experimental Immunology, IRCCS Ospedale San Raffaele, Milan, Italy.
[3]
Unit of Immunotherapy and Anticancer Innovative Therapeutics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
[4]
Unit of Tumor Immunology, IRCCS Ospedale San Raffaele, Milan, Italy.
[5]
Unit of Molecular Immunology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
[6]
Department of Inflammation and Immunology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
[7]
University of Padua, Padua, Italy.
[8]
Oncology Unit, ASST Valle Olona, Ospedale di Circolo di Busto Arsizio, Busto Arsizio, Italy.
[9]
Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy.
[10]
European Institute of Oncology IRCCS, Milan, Italy.
[11]
Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore Di Sanità, Rome, Italy.
[12]
Unit of Immuno-Biotherapy of Melanoma and Solid Tumors, IRCCS Ospedale San Raffaele, Milan, Italy. russo.vincenzo@hsr.it.
[13]
DOI
10.1007/s00262-020-02502-1
PMID
32025818
发布时间
2024-04-26
换一批
换一批
